<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="12730">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02941198</url>
  </required_header>
  <id_info>
    <org_study_id>110</org_study_id>
    <nct_id>NCT02941198</nct_id>
  </id_info>
  <brief_title>Postpartum Immediate Contraception in Cesarean Deliveries-Comparison of Two Intrauterine Systems</brief_title>
  <official_title>Comparative of Two Devices (Conventional Intrauterine Devices (Cu T380 A)/Frameless Intrauterine Devices (GyneFix)) for Postpartum Immediate Contraception in Cesarean Deliveries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zeynep Kamil Maternity and Pediatric Research and Training Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zeynep Kamil Maternity and Pediatric Research and Training Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare two intrauterine systems in order to avoid complications originating from short
      pregnancy interval and undesired pregnancies in the early postpartum period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients admitting to Zeynep Kamil Research and Training Hospital for caesarean delivery
      will be included in the study. There will be two computer based randomized groups. The
      investigators expect that both groups will have 100 cases. First group will be treated with
      conventional intrauterine devices (Cu T380 A) while the second group will be treated with
      frameless intrauterine devices (GyneFix). The participants will be informed about postpartum
      unplanned pregnancies and the complications of short pregnancy interval. Participants will
      also be informed about possible complications of having an intrauterine device and that
      there may be a possibility of failure.The participants who choose to participate in the
      study will be divided into two groups by computer based randomization and one of the systems
      will be applied. After the participants read and sign the informed consent form, the
      intrauterine device will be applied postplacental up to 10 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by conventional intrauterine devices (Cu T380 A) and frameless intrauterine devices (GyneFix)</measure>
    <time_frame>The patients will be seen postoperative 6th week</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Intrauterine Systems</condition>
  <condition>Postpartum Immediate Contraception</condition>
  <arm_group>
    <arm_group_label>frameless intrauterine devices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The GyneFixÂ® 200 IUD is only 2 cm long. Its small surface area is 1/3 of that of the conventional T-shaped IUDs such as TCu380A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional intrauterine devices</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional T-shaped IUDs such as TCu380A</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GyneFix</intervention_name>
    <description>The fiber is fixed to the anchoring thread by means of a stainless steel clip 1 cm from the upper part of the anchoring knot. The anchoring knot is implanted into the myometrium of the uterus thus permanently securing the implant in the uterine cavity</description>
    <arm_group_label>frameless intrauterine devices</arm_group_label>
    <other_name>frameless intrauterine devices</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cu T380 A</intervention_name>
    <description>An IUD is inserted into the uterus</description>
    <arm_group_label>conventional intrauterine devices</arm_group_label>
    <other_name>conventional intrauterine devices</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients who read and sign the informed consent form.

        Exclusion Criteria:

          -  The patient who has more than 6 cm dilatation, prolonged premature rupture of the
             membranes (more than 12 hours), chorioamnionitis, and kongenital or acquired
             haemorragic diathesis will be excluded from the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zeynep Kamil Maternity and Children's Training and Research Hospital, Department of Obstetrics and Gynecology</name>
      <address>
        <city>Istanbul</city>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ahmet eser, medical doctor</last_name>
      <phone>+905056179623</phone>
      <email>drahmeteser@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zeynep Kamil Woman and Child Diseases Education and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmet eser, md</last_name>
      <phone>5056179623</phone>
      <email>drahmeteser@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Hooda R, Mann S, Nanda S, Gupta A, More H, Bhutani J. Immediate Postpartum Intrauterine Contraceptive Device Insertions in Caesarean and Vaginal Deliveries: A Comparative Study of Follow-Up Outcomes. Int J Reprod Med. 2016;2016:7695847. doi: 10.1155/2016/7695847.</citation>
    <PMID>27631023</PMID>
  </reference>
  <reference>
    <citation>Lopez LM, Bernholc A, Hubacher D, Stuart G, Van Vliet HA. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database Syst Rev. 2015 Jun 26;(6):CD003036. doi: 10.1002/14651858.CD003036.pub3. Review.</citation>
    <PMID>26115018</PMID>
  </reference>
  <reference>
    <citation>Singal S, Bharti R, Dewan R, Divya, Dabral A, Batra A, Sharma M, Mittal P. Clinical Outcome of Postplacental Copper T 380A Insertion in Women Delivering by Caesarean Section. J Clin Diagn Res. 2014 Sep;8(9):OC01-4. doi: 10.7860/JCDR/2014/10274.4786.</citation>
    <PMID>25386484</PMID>
  </reference>
  <reference>
    <citation>Bhutta SZ, Butt IJ, Bano K. Insertion of intrauterine contraceptive device at caesarean section. J Coll Physicians Surg Pak. 2011 Sep;21(9):527-30. doi: 09.2011/JCPSP.527530. Erratum in: J Coll Physicians Surg Pak. 2011 Nov;21(11):717.</citation>
    <PMID>21914407</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 20, 2016</lastchanged_date>
  <firstreceived_date>October 12, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zeynep Kamil Maternity and Pediatric Research and Training Hospital</investigator_affiliation>
    <investigator_full_name>Ahmet Eser</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
